Apremilast therapy increases CD39<sup>+</sup>CD4<sup>+</sup> T cells in peripheral blood of patients with psoriatic disease: a retrospective observational pilot study. [PDF]
Mavropoulos A +6 more
europepmc +1 more source
Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer. [PDF]
Deiber M +7 more
europepmc +1 more source
Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review. [PDF]
de Oliveira EM +4 more
europepmc +1 more source
Genetically predicted serum Pimelylcarnitine mediates the association between CD39+ secreting Treg cells and intervertebral disc degeneration. [PDF]
Li N +6 more
europepmc +1 more source
Anemia in a Cohort of Greek Patients with Sickle Cell Disease: Clinical Insights and Therapeutic Challenges. [PDF]
Diamantidis MD +8 more
europepmc +1 more source
Genital Tract and Circulating CD8+ T Cell Phenotypes Vary Across the Menstrual Cycle. [PDF]
Talavera IC +16 more
europepmc +1 more source
Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma. [PDF]
Najjar YG +6 more
europepmc +1 more source
Mass Cytometry Reveals Comparable Proportions of Leukocyte Subsets and Cell Surface P2X7 or CD39 on Human Peripheral Blood Mononuclear Cell Samples Isolated by Ficoll-Paque or SepMate Tube Density Gradient Centrifugation. [PDF]
Elhage A +6 more
europepmc +1 more source
CD39 And Control of Cellular Immune Responses [PDF]
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) family. Biological actions of CD39 are a consequence (at least in part) of the regulated phosphohydrolytic activity on extracellular ...
Simon C. Robson +2 more
exaly +8 more sources

